从2015年到2024年,对动脉样硬化中的铁亡的图书统计分析
Ke-Qian Chen1, Wei Li1, Shu-Zhi Wang2
1Department of Clinical Pharmacy, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan 411100, China.
The Journal of pharmacy and pharmacology
|November 25, 2025
概括
这种图书统计分析揭示了铁和动脉样硬化的研究趋势. 它强调了对这一领域做出贡献的关键作者,机构和国家,为未来关于动脉样硬化中铁死抑制的研究提供了见解.
科学领域:
- 生物医学研究的研究.
- 心血管科学 心血管科学
- 细胞生物学 细胞生物学
背景情况:
- 铁亡因其在疾病中的作用得到越来越多的认可.
- 抑制铁亡是治疗动脉样硬化的有希望的方法.
- 在动脉样硬化研究中缺乏铁亡的文献分析.
研究的目的:
- 分析铁和动脉样硬化的研究趋势.
- 为未来在这一领域的研究提供有价值的参考资料.
- 为了更深入地了解铁死在动脉样硬化中的作用.
主要方法:
- 使用科学网络核心数据库 (SCI EXPANDED) 的图书法分析.
- 从2015年1月到2024年12月,搜索了"铁"和"动脉样硬化".
- 使用VOSviewer和CiteSpace进行作者,机构,国家,期刊和关键词的视觉和集群分析.
主要成果:
- 分析了274篇涉及1774位作者,363个机构,32个国家,153个期刊和1212个关键词的文章.
- 中国在出版方面领先,哈尔医学大学和孙中山大学是关键机构.
- 铁化是最频繁和共同出现的关键词,表明其核心作用.
结论:
- 这项研究提供了关于铁和动脉样硬化的研究景观的全面概述.
- 确定了主要贡献者和合作模式,以指导未来的研究方向.
- 突出了铁灭症作为动脉样硬化研究中的研究重点的重要性.
更多相关视频
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.7K
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
4.3K
相关概念视频
Atherosclerosis I: Introduction
835
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
444
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
444
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Coronary Artery Disease II: Pathophysiology
348
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348
